Childhood leukemia chemo leaves lasting nerve damage in survivors
NCT ID NCT05759052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how common nerve damage is in adults who had vincristine chemotherapy for childhood leukemia. 467 survivors were assessed using a questionnaire about nerve symptoms. The goal was to understand how often and how severe this side effect is long after treatment ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Smartwatch could spot nerve damage before it starts
- Could simple leg exercises restore balance and blood flow after chemotherapy?
- Could a simple vibrating pad ease chemo nerve damage?
- Blood test may predict nerve damage from common chemo drug
- Could light therapy ease Chemo's nerve pain?